Adrenal Tumors - Pathogenesis and Therapy
Investigation of the Tumorigenesis of Adrenal Tumors and Evaluation of New Therapeutic Options - Untersuchungen Zur Tumorgenese Von Nebennierentumoren Und Evaluation Neuer Therapieoptionen
Sponsor: Deutsche Krebshilfe e.V., Bonn (Germany)
Listed as NCT00669266, this observational or N/A phase trial focuses on Adrenal Tumors and Adrenocortical Carcinoma and remains actively recruiting participants. Sponsored by Deutsche Krebshilfe e.V., Bonn (Germany), it has been updated 15 times since 2002, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
15 versions recorded-
Sep 2025 — Present [monthly]
Recruiting
-
Sep 2024 — Sep 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
May 2024 — Jul 2024 [monthly]
Recruiting
-
Mar 2023 — May 2024 [monthly]
Recruiting
▶ Show 10 earlier versions
-
Dec 2021 — Mar 2023 [monthly]
Recruiting
-
Sep 2021 — Dec 2021 [monthly]
Recruiting
-
Jan 2021 — Sep 2021 [monthly]
Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
-
Sep 2018 — Nov 2020 [monthly]
Recruiting
-
Jun 2018 — Sep 2018 [monthly]
Recruiting
-
May 2018 — Jun 2018 [monthly]
Recruiting
-
Apr 2018 — May 2018 [monthly]
Recruiting
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Recruiting NA
-
Jan 2017 — Aug 2017 [monthly]
Recruiting NA
First recorded
Sep 2002
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Deutsche Krebshilfe e.V., Bonn (Germany)
- German Federal Ministry of Education and Research
- University of Wuerzburg
For direct contact, visit the study record on ClinicalTrials.gov .